Run for the Lung is back for its 13th year
A 5km run in support of CFC
Did you know that your version of Internet Explorer is out of date?
To get the best possible experience using our website we recommend downloading one of the browsers below.
Newborn screening for cystic fibrosis is a vital tool to help slow the progression of this fatal genetic disease. Newborn screening is the process of testing newborns for specific disorders. Shortly after a baby is born, a doctor or nurse takes a small blood sample from the heel of the baby’s foot. The sample is sent to a laboratory, where it is tested for a number of disorders. One of the tests detects cystic fibrosis.
Early diagnosis for cystic fibrosis through newborn screening allows for immediate intervention and treatment. Early interventions have been shown to: improve height, weight, and cognitive function, help maintain healthy respiratory function and reduce hospitalizations; they may also increase life expectancy. Ultimately, newborn screening can lead to longer, healthier lives.
Without newborn screening, irreversible damage to the lungs and digestive system may occur. Parents and families endure months or years of anguish trying to understand their child’s health condition before cystic fibrosis is finally diagnosed.
In 2017, Cystic Fibrosis Canada has celebrated a huge win as the implementation of a screening program for CF in newborns was announced in Quebec. This announcement resulted from the successful mobilization of the Canadian CF community around the importance of newborn screening for Canadian babies with CF. The newborn screening program is now in practice for all births in all provinces across Canada, and essential to early diagnosis and intervention.